[go: up one dir, main page]

CO2020002287A2 - Composiciones farmacéuticas - Google Patents

Composiciones farmacéuticas

Info

Publication number
CO2020002287A2
CO2020002287A2 CONC2020/0002287A CO2020002287A CO2020002287A2 CO 2020002287 A2 CO2020002287 A2 CO 2020002287A2 CO 2020002287 A CO2020002287 A CO 2020002287A CO 2020002287 A2 CO2020002287 A2 CO 2020002287A2
Authority
CO
Colombia
Prior art keywords
pharmaceutical compositions
active ingredient
compositions
medicine
processes
Prior art date
Application number
CONC2020/0002287A
Other languages
English (en)
Inventor
Stephen John Pethen
Gary Cook
Sally Louise Marsh
Michael Bryan Roe
Christopher Martyn Yea
Original Assignee
Kalvista Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1713660.7A external-priority patent/GB201713660D0/en
Application filed by Kalvista Pharmaceuticals Ltd filed Critical Kalvista Pharmaceuticals Ltd
Publication of CO2020002287A2 publication Critical patent/CO2020002287A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se relaciona con composiciones farmacéuticas en solución acuosa que comprenden por lo menos un agente de tonicidad no iónico, por lo menos una solución tampón y un ingrediente activo, caracterizadas porque dicho ingrediente activo es un compuesto de la fórmula I (I) caracterizado porque R1-R9 están definidos en el presente documento; los procesos para la preparación de estas composiciones y su uso en medicina, en especial su uso en el tratamiento de las enfermedades oculares.
CONC2020/0002287A 2017-08-11 2020-02-28 Composiciones farmacéuticas CO2020002287A2 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762544346P 2017-08-11 2017-08-11
GBGB1713660.7A GB201713660D0 (en) 2017-08-25 2017-08-25 Pharmaceutical compositions
PCT/GB2018/052292 WO2019030540A1 (en) 2017-08-11 2018-08-13 PHARMACEUTICAL COMPOSITIONS

Publications (1)

Publication Number Publication Date
CO2020002287A2 true CO2020002287A2 (es) 2020-06-09

Family

ID=70976595

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2020/0002287A CO2020002287A2 (es) 2017-08-11 2020-02-28 Composiciones farmacéuticas

Country Status (8)

Country Link
CL (1) CL2020000356A1 (es)
CO (1) CO2020002287A2 (es)
EC (1) ECSP20017939A (es)
IL (1) IL272428A (es)
MX (1) MX2020001356A (es)
PH (1) PH12020500246A1 (es)
RU (1) RU2020109955A (es)
UA (1) UA125537C2 (es)

Also Published As

Publication number Publication date
IL272428A (en) 2020-03-31
RU2020109955A (ru) 2021-09-14
ECSP20017939A (es) 2020-04-22
MX2020001356A (es) 2020-03-20
PH12020500246A1 (en) 2021-03-15
RU2020109955A3 (es) 2022-01-24
UA125537C2 (uk) 2022-04-13
CL2020000356A1 (es) 2020-06-19

Similar Documents

Publication Publication Date Title
ECSP19030002A (es) 1,2,4-triazolonas 2,4,5-trisustituidas
MX2022014313A (es) Formulaciones para administracion oral de agentes activos con perfil de absorcion controlada.
CO2020001244A2 (es) Derivados de quinolina para tratar infecciones con helmintos
CL2020002252A1 (es) Formulación oftálmica.
UY37789A (es) Nuevos derivados de azaquinolina
CR20170411A (es) Composiciones farmacéuticas que comprenden n-(3,5-dimetoxifenil)-n-(1-metiletil)-n-[3-(1-metil-1h-pirazol-4-il-quin oxalin-6-il]etano-1,2-diamina
PE20191650A1 (es) Derivados de indolina sustituidos como inhibidores de la replicacion virica de dengue
CO2019011877A2 (es) Nuevos derivados de pirazol bicíclicos
MX2019013878A (es) Derivados de indolina sustituidos como inhibidores de la replicacion virica de dengue.
MX2018011785A (es) Derivados de indolina sustituidos como inhibidores de la replicacion viral del dengue.
UY37496A (es) Hemihidrato de la base libre de n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil]-acetamida, métodos de fabricación y usos del mismo
MX2019013893A (es) Derivados de indolina sustituidos como inhibidores de la replicacion virica de dengue.
CO2019011546A2 (es) Compuestos y métodos para el tratamiento de enfermedades parasitarias
CL2019003572A1 (es) Combinaciones de brimonidina de dosis baja y usos de las mismas.
PE20171246A1 (es) Formulaciones farmaceuticas que comprenden cangrelor de alta pureza y metodos para la preparacion y uso de los mismos
CO2019004004A2 (es) Composición farmacéutica y método para el tratamiento de la enfermedad del hígado graso no alcohólico
MX2023006235A (es) Composiciones para administracion de farmacos y metodos de uso de las mismas.
NI201900063A (es) Amidas aromáticas de ácido carboxílico
AR110250A1 (es) Formulación tópica que comprende n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil]-acetamida
CL2021002107A1 (es) Triamtereno o nolatrexed para uso en el tratamiento de fenilcetonuria.
CO2021008962A2 (es) Derivados activos de éster de testosterona, composiciones y usos de los mismos
CO2020002287A2 (es) Composiciones farmacéuticas
CO2020000292A2 (es) Preparación medicinal combinada para tratar infecciones virales
MX2017009863A (es) Agente preventivo y/o terapeutico de enfermedad inmune.
CO2022002493A2 (es) Nanoemulsion de ácido 18p-glicirretínico